HOME PRODUCTS COMPANY CONTACT FAQ

Research Dictionary Pharma

Sign Up FREE or Login

N-glycylglutamic acid

RN given refers to (L)-isomer

Also Known As:

Gly-Glu

Networked: 14 relevant articles (0 outcomes, 3 trials/studies)

Bio-Agent Context: Research Results

Amino Acids, Peptides, and Proteins: 1
- Peptides: 82426
  - Oligopeptides: 519
    - Dipeptides: 945
      - N-glycylglutamic acid: 14

Experts

1.	Guo, Haixun: 5 articles (06/2012 - 02/2008)
2.	Miao, Yubin: 5 articles (06/2012 - 02/2008)
3.	Gallazzi, Fabio: 4 articles (06/2012 - 02/2008)
4.	Yang, Jianquan: 3 articles (04/2011 - 04/2009)
5.	Sklar, Larry A: 2 articles (11/2009 - 04/2009)
6.	Ayabe, Tatsuhiro: 1 article (08/2015)
7.	Han, Li: 1 article (08/2015)
8.	Hayamizu, Kohsuke: 1 article (08/2015)
9.	Kanamoto, Ryuhei: 1 article (08/2015)
10.	Kawabata, Fuminori: 1 article (08/2015)

Related Diseases

1.	Melanoma (Melanoma, Malignant) 04/01/2011 - "The purpose of this study was to examine the profound effects of the amino acid linkers on the melanoma-targeting and pharmacokinetic properties of (111)In-labeled lactam bridge-cyclized DOTA-[X]-CycMSH(hex) {1,4,7,10-tetraazacyclododecane-1,4,7,10-tetraacetic acid-[X]-c[Asp-His-dPhe-Arg-Trp-Lys]-CONH(2); X = GGNle, GENle, or NleGE; GG = -Gly-Gly- and GE = -Gly-Glu-} peptides. " 04/01/2009 - "The purpose of this study was to examine whether a novel lactam bridge-cyclized (111)In-labeled 1,4,7,10-tetraazacyclododecane-1,4,7,10-tetraacetic acid-Gly-Glu-c[Lys-Nle-Glu-His-d-Phe-Arg-Trp-Gly-Arg-Pro-Val-Asp] {DOTA-GlyGlu-CycMSH} could be an effective imaging probe for metastatic melanoma detection. " 11/01/2009 - "Melanoma targeting and pharmacokinetic properties of Ac-GluGlu-CycMSH[DOTA]-111In were determined in B16/F1 melanoma-bearing C57 mice and compared to that of 111In-DOTA-Gly-Glu-c[Lys-Nle-Glu-His-DPhe-Arg-Trp-Gly-Arg-Pro-Val-Asp] (111In-DOTA-GlyGlu-CycMSH; DOTA was coupled to the N-terminus of the peptide). " 06/20/2012 - "The purpose of this study was to examine the melanoma targeting and pharmacokinetic properties of (67)Ga-DOTA-GGNle-CycMSHhex {(67)Ga-1,4,7,10-tetraazacyclononane-1,4,7,10-tetraacetic acid-Gly-Gly-Nle-c[Asp-His-DPhe-Arg-Trp-Lys]-CONH2} and (67)Ga-NOTA-GGNle-CycMSHhex {(67)Ga-1,4,7-triazacyclononane-1,4,7-triacetic acid-Gly-Gly-Nle-c[Asp-His-DPhe-Arg-Trp-Lys]-CONH2} and compare with (67)Ga-DOTA-GlyGlu-CycMSH {(67)Ga-DOTA-Gly-Glu-c[Lys-Nle-Glu-His-DPhe-Arg-Trp-Gly-Arg-Pro-Val-Asp]} we previously reported. "
2.	Multiple System Atrophy 07/01/2003 - "We reported a 69-year-old woman with multiple system atrophy (MSA), who had a heteroallelic missense mutation (G1874A, Gly-->Glu) in the exon 11 of the ceruloplasmin (Cp) gene. "
3.	Hepatoerythropoietic Porphyria 01/01/1988 - "Prevalence of the 281 (Gly----Glu) mutation in hepatoerythropoietic porphyria and porphyria cutanea tarda." 01/01/1988 - "The prevalence of the 281 (Gly----Glu) mutation in hepatoerythropoietic porphyria (HEP) was investigated by the use of hybridization with a synthetic oligonucleotide probe. "
4.	Porphyria Cutanea Tarda 01/01/1988 - "Prevalence of the 281 (Gly----Glu) mutation in hepatoerythropoietic porphyria and porphyria cutanea tarda."
5.	Wounds and Injuries (Trauma) 12/01/2023 - "Herein, a nanofibrous membrane wound dressing material based on recombinant human collagen type III (rhCol III) crosslinked by EDC/NHS (rhCol III EN NF), which incorporated multiple Gly-Glu-Lys (GEK) and Gly-Leu-Ser-Gly-Glu-Arg (GLSGER) integrin receptors, has been developed utilizing green electrospinning technology. "

Related Drugs and Biologics

1.	1,4,7,10-tetraazacyclododecane- 1,4,7,10-tetraacetic acid
2.	arginylproline
3.	lysinenorleucine
4.	Lactams
5.	Acids
6.	Peptides (Polypeptides)
7.	Amino Acids
8.	tryptophylglycine
9.	triazacyclononane
10.	ACTH (7-10)